Skip to main content
Ind-Swift Laboratories Ltd. logo

Ind-Swift Laboratories Ltd. — Investor Relations & Filings

Ticker · INDSWFTLAB ISIN · INE915B01019 LEI · 335800ZT8UFD9Y8ZMP56 BSE.NS Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2024-05-22 Regulatory Filings
Country IN India
Listing BSE.NS INDSWFTLAB

About Ind-Swift Laboratories Ltd.

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd. is a global manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. The company focuses on research and development, process chemistry, and large-scale production across diverse therapeutic segments, including macrolide antibiotics, cardiovascular agents, antihistamines, antidiabetics, and antipsychotics. Operating multiple manufacturing facilities that adhere to international regulatory standards such as USFDA, EDQM, and PMDA, the organization provides high-quality chemical entities to the global market. Its core competencies lie in complex chemical synthesis and the development of cost-effective manufacturing processes for generic and specialty drug substances. The company maintains a strong emphasis on quality assurance and regulatory compliance to support its extensive portfolio of products distributed worldwide.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2024-05-22 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice regarding a Postal Ballot for shareholders of Ind-Swift Laboratories Limited. It includes the notice of the Postal Ballot, explanatory statements, resolutions to be passed by shareholders, voting instructions, and procedural details. The content focuses on seeking shareholder approval for increasing authorized share capital, altering articles of association, and approving related party transactions. It is not a report of voting results, nor is it a brief announcement or a certification. The document is not an annual or interim financial report, earnings release, or management discussion. It is a formal communication to shareholders to solicit votes on specific corporate actions via Postal Ballot, which fits the category of Proxy Solicitation & Information Statement (PSI). The length and detail confirm it is the actual solicitation material, not just an announcement or summary.
2024-05-21 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is an official communication titled 'Outcome of Board Meeting held on May 18, 2024' from Ind Swift Laboratories Ltd. It details decisions made by the Board of Directors, including approval of a valuation report and fairness opinion related to a merger, amendments to the Scheme of Arrangement, increase in authorized share capital, amendments to the Articles of Association, and approval of a postal ballot notice. The document is addressed to stock exchanges and references compliance with SEBI Listing Regulations. It is a disclosure of board meeting outcomes rather than the full board report or minutes. It does not contain detailed financial statements or comprehensive management discussion but rather summarizes key board decisions and approvals. Therefore, it fits best under 'Board/Management Information (MANG)' as it announces changes and approvals made by the board, including corporate actions and governance matters. The document length (5115 characters) and content confirm it is not a full financial report or regulatory filing but a board meeting outcome announcement.
2024-05-18 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI Listing Regulations regarding the incorporation of a wholly owned subsidiary. It provides details about the new subsidiary, including its name, incorporation date, and business purpose. The document is addressed to stock exchanges and serves as a regulatory disclosure about a corporate event (incorporation of a subsidiary). It does not contain financial statements, earnings data, or detailed management discussion. It is a regulatory announcement about a corporate action, specifically a capital/financing update related to the company's structure. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is about 4828 characters, which is consistent with a detailed announcement but not a full report.
2024-05-18 English
Updates
Regulatory Filings
2024-05-13 English
Financial Result Updates
Regulatory Filings
2024-05-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.